George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDODS.L Regulatory News (DODS)

  • There is currently no data for DODS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

30 Mar 2021 07:00

RNS Number : 8709T
Dods Group PLC
30 March 2021
 

30 March 2021

Dods Group plc

 

 ("Dods", the "Company" or "the Group")

 

Trading update

 

 

Dods Group plc (AIM: DODS), the data and intelligence business, provides the following update on trading in the year just ending on 31 March 2021.

 

Trading in the second half of the year has recovered strongly after the first half was impacted by the advent of the Covid pandemic.

 

Net Income*

Dods Technology's achieved double digit net income growth in the second half when compared to the first - with increased spend from existing clients, new project wins and a rebound in some tactical revenues which had been impacted by Covid19, in the earlier part of the year. The business benefits from strong levels of recurring revenue from long term contracts.

 

Dods Intelligence, which was heavily impacted by the inability to hold physical events and training in the first half, has recovered by moving much of its operation online, net income in this division has grown very strongly half on half.

 

Profitability

The Group expects to report an adjusted EBITDA** for the full year of at least £1.8 million compared with an adjusted EBITDA loss of £0.2 million in the first half.

 

*Net income is revenue less the cost of sales directly related to provision of services to customers.

**Adjusted EBITDA is calculated as earnings before tax, depreciation, amortisation of intangible assets, share based payments and non-recurring items. 

 

Cash

The Group has come through a difficult 2020 with a robust balance sheet, year-end net cash will be no less than £0.4 million; (31 March 2020 £1.4 million). The Group expects to have approximately £5.0 million of cash available including its fully drawn debt facility of £4.6 million.

 

The Group benefited during the period from deferred liabilities of £1.7 million, of which deferred VAT is the most significant element. This position is expected to unwind during the course of the coming financial year. There are no other temporary Covid19 relief measures that are impacting the company's balance sheet. Due to the positive cash flow of the Group, the Board has already resumed debt repayments.

 

 

Mark Smith, Non-Executive Chairman, commented:

 

"We have seen a strong recovery in the second half of the financial year which is a testament to the hard work and adaptability of our people, the loyalty of our clients and the strength of our offer. We look forward to providing further detail in our full preliminary results statement in July."

 

 

 

This announcement is released by Dods Group plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

 

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Group by Simon Bullock, Chief Financial Officer.

 

 

 

 

 

For further information, please contact:

 

Dods Group plc

Mark Smith - Non-Executive Chairman 020 7593 5500

www.dodsgroup.com

 

Canaccord Genuity Limited (Nomad and Broker)

Bobbie Hilliam 020 7523 8150

Georgina McCooke

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUAGWUPGGMB
Date   Source Headline
20th Apr 20214:05 pmRNSHolding(s) in Company
16th Apr 202111:30 amRNSResult of General Meeting
1st Apr 20217:00 amRNSPosting of Circular and Notice of GM
30th Mar 20217:01 amRNSChange of Name and Share Capital Reorganisation
30th Mar 20217:00 amRNSTrading Update
30th Nov 20207:00 amRNSHalf-year Report
26th Nov 202011:35 amRNSBoard Changes
12th Oct 20204:23 pmRNSHolding(s) in Company
29th Sep 202012:21 pmRNSResult of AGM
4th Sep 202012:31 pmRNSAnnual Financial Report
3rd Sep 20207:02 amRNSFinal Results
3rd Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
5th Aug 20202:02 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSIssue of Shares and Director / PDMR Dealing
1st Jul 202010:52 amRNSDirectorate Change
18th Jun 20207:00 amRNSDr David Hammond
1st Jun 20202:06 pmRNSBoard Appointments
1st Jun 20207:00 amRNSUpdated Debt Facilities
23rd Apr 20207:06 amRNSAppointment of CFO and COVID-19 Update
18th Mar 20205:46 pmRNSAIM Rule 17 Notification
24th Feb 20203:47 pmRNSDirectorate Change
22nd Jan 20202:52 pmRNSDirectorate Change
22nd Jan 20207:00 amRNSTrading Update
29th Oct 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSChange of Adviser
25th Sep 20198:59 amRNSAIM Rule 17 Schedule Two (g) Update
2nd Sep 20197:00 amRNSDirectorate Change
29th Aug 20194:07 pmRNSResult of AGM
23rd Jul 20197:00 amRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20191:42 pmRNSCompletion of Acquisition
18th Jul 20198:48 amRNSDirector/PDMR Shareholding
18th Jul 20198:46 amRNSAnnual Financial Report
16th Jul 201910:39 amRNSResult of General Meeting and Open Offer
28th Jun 20198:47 amRNSGeneral Meeting & Open Offer Timetable
28th Jun 20197:00 amRNSFinal Results
28th Jun 20197:00 amRNSAcquisition, Fundraising and Notice of GM
11th Jun 20197:00 amRNSAcquisition of Meritgroup
10th Jun 20197:00 amRNSResponse re. Press Speculation
21st May 20197:00 amRNSAppointment of Chief Revenue Officer
29th Apr 20197:00 amRNSAppointment of Chief Information Officer
21st Jan 20197:00 amRNSTrading Statement
5th Dec 20181:50 pmRNSHolding(s) in Company
5th Dec 20181:50 pmRNSHolding(s) in Company
14th Nov 20187:00 amRNSHalf-year Report
21st Sep 201811:17 amRNSLong Term Incentive Plan
14th Aug 201812:39 pmRNSDirectorate Change
7th Aug 20184:14 pmRNSDirector/PDMR Shareholding
1st Aug 20189:52 amRNSDirectorate Change
1st Aug 20189:24 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.